Gene Therapy - Table of Contents alert Volume 19 Issue 5

TABLE OF CONTENTS Volume 19, Issue 5 (May 2012) In this issue Enabling Technologies Original Articles Short Communication Corrigendum Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Nature Genetics and the Wellcome Trust present: The Genomics of Common Diseases 2012 September 19-22, 2012 - Potomac, MD, USA For more information and to register, visit: www.nature.com/natureconferences/gcd2012 Abstract submission deadline- June 28, 2012   Enabling Technologies Top Mitochondrial gene replacement in human pluripotent stem cell-derived neural progenitors S Iyer, E Xiao, K Alsayegh, N Eroshenko, M J Riggs, J P Bennett, Jr and R R Rao Gene Ther 2012 19: 469-475; advance online publication, September 15, 2011; 10.1038/gt.2011.134 Abstract | Full Text Original Articles Top Interleukin-10 expression induced by adeno-associated virus vector suppresses proteinuria in Zucker obese rats M Ogura, M Urabe, T Akimoto, A Onishi, C Ito, T Ito, T Tsukahara, H Mizukami, A Kume, S Muto, E Kusano and K Ozawa Gene Ther 2012 19: 476-482; advance online publication, November 24, 2011; 10.1038/gt.2011.183 Abstract | Full Text Sustained induction of neuronal addition to the adult rat neostriatum by AAV4-delivered noggin and BDNF A Benraiss, E Bruel-Jungerman, G Lu, A N Economides, B Davidson and S A Goldman Gene Ther 2012 19: 483-493; advance online publication, September 15, 2011; 10.1038/gt.2011.114 Abstract | Full Text Novel Clostridium perfringens enterotoxin suicide gene therapy for selective treatment of claudin-3- and -4-overexpressing tumors W Walther, S Petkov, O N Kuvardina, J Aumann, D Kobelt, I Fichtner, M Lemm, J Piontek, I E Blasig, U Stein and P M Schlag Gene Ther 2012 19: 494-503; advance online publication, October 6, 2011; 10.1038/gt.2011.136 Abstract | Full Text DNA delivery to ‘ex vivo’ human liver segments M J Herrero, L Sabater, G Guenechea, L Sendra, A I Montilla, R Abargues, V Navarro and S F Aliño Gene Ther 2012 19: 504-512; advance online publication, October 13, 2011; 10.1038/gt.2011.144 Abstract | Full Text Hypoxia-specific GM-CSF-overexpressing neural stem cells improve graft survival and functional recovery in spinal cord injury H J Kim, J S Oh, S S An, W A Pennant, S-J Gwak, A N Kim, P K Han, D H Yoon, K N Kim and Y Ha Gene Ther 2012 19: 513-521; advance online publication, October 20, 2011; 10.1038/gt.2011.137 Abstract | Full Text LOX-1 abrogation reduces cardiac hypertrophy and collagen accumulation following chronic ischemia in the mouse J Lu, X Wang, W Wang, H Muniyappa, C Hu, S Mitra, B Long, K Das and J L Mehta Gene Ther 2012 19: 522-531; advance online publication, September 22, 2011; 10.1038/gt.2011.133 Abstract | Full Text Suicidal gene therapy in the effective control of primary human hepatocellular carcinoma as monitored by noninvasive bioimaging K C Sia, H Huynh, N Chinnasamy, K M Hui and P Y P Lam Gene Ther 2012 19: 532-542; advance online publication, September 15, 2011; 10.1038/gt.2011.131 Abstract | Full Text Dynamics of melanoma tumor therapy with vesicular stomatitis virus: explaining the variability in outcomes using mathematical modeling D M Rommelfanger, C P Offord, J Dev, Z Bajzer, R G Vile and D Dingli Gene Ther 2012 19: 543-549; advance online publication, September 15, 2011; 10.1038/gt.2011.132 Abstract | Full Text Nonviral gene delivery of erythropoietin by mesenchymal stromal cells F Scheibe, N Gladow, P Mergenthaler, A H Tucker, A Meisel, D J Prockop and J Priller Gene Ther 2012 19: 550-560; advance online publication, September 29, 2011; 10.1038/gt.2011.139 Abstract | Full Text Early intra-amniotic gene transfer using lentiviral vector improves skin blistering phenotype in a murine model of Herlitz junctional epidermolysis bullosa M Endo, P W Zoltick, A Radu, J Qiujie, C Matsui, P M Marinkovich, J McGrath, K Tamai, J Uitto and A W Flake Gene Ther 2012 19: 561-569; advance online publication, September 22, 2011; 10.1038/gt.2011.135 Abstract | Full Text Mtb32 is a promising tuberculosis antigen for DNA vaccination in pre- and post-exposure mouse models S-S Ahn, B-Y Jeon, K-S Kim, J-Y Kwack, E-G Lee, K-S Park, Y-C Sung and S-N Cho Gene Ther 2012 19: 570-575; advance online publication, September 29, 2011; 10.1038/gt.2011.140 Abstract | Full Text Short Communication Top Bovine AAV transcytosis inhibition by tannic acid results in functional expression of CFTR in vitro and altered biodistribution in vivo G Di Pasquale, L Ostedgaard, D Vermeer, W D Swaim, P Karp and J A Chiorini Gene Ther 2012 19: 576-581; advance online publication, October 20, 2011; 10.1038/gt.2011.138 Abstract | Full Text Corrigendum Top Sustained induction of neuronal addition to the adult rat neostriatum by AAV4-delivered noggin and BDNF A Benraiss, E Bruel-Jungerman, G Lu, A N Economides, B Davidson and S A Goldman Gene Ther 2012 19: 582; advance online publication, November 10, 2011; 10.1038/gt.2011.182 Full Text Advertisement Pediatric Research Reviews Highlights Cell-based therapies in 2012 Published in April 2012 as a special supplemental issue of Pediatric Research, the annual review issue highlights cell-based therapies in pediatrics. The articles in this issue examine developments in cell-based therapies used for treating neonatal/pediatric neuronal damage, hematologic diseases, chronic inflammatory diseases and cancers. Visit www.nature.com/pr and gain access to these articles before they are published in print.   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.